Related Experiment Video
Updated: Aug 29, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Reduced expression of organic cation transporters rOCT1 and rOCT2 in experimental diabetes
Brett Grover1, Donna Buckley, Arthur R Buckley
1College of Pharmacy, University of Cincinnati Medical Center, Cincinnati, OH 45267-0004, USA.
Abstract:
Recent reports have documented a functional deficit of organic cation transport in diabetic rats by an unknown mechanism. This study was designed to test the hypothesis that experimental diabetes decreases expression of organic cation transporters at the basolateral membrane. Streptozotocin-induced diabetic rats were maintained for varying durations after induction of diabetes. A second group of age-matched control rats was maintained in a parallel manner. Kinetic analysis of tetraethylammonium accumulation in freshly isolated proximal tubular cells indicated a significantly lower V(max) value for the diabetics versus controls with no statistical difference in K(m) values between the two groups. Cortex sections were processed by standard procedures for Northern and immunoblot analysis. Protein expression of the organic cation transporters rOCT1 and rOCT2 progressively decreased with increasing duration of diabetes. After 21 days of diabetes, rOCT1 and rOCT2 were maximally reduced by 50 and 70%, respectively. Quantification of mRNA expression revealed that the roct1 transcript remained unchanged, whereas the roct2 transcript was decreased by 50% after 14 days of diabetes. Treatment with insulin prevented the reductions in transporter levels. These results support the hypothesis by demonstrating that experimental diabetes decreased expression of both rOCT1 and rOCT2 protein and also of roct2 mRNA accumulation. On the other hand, roct1 mRNA levels were unaffected by the diabetic state. This suggests that differences in rOCT2 protein may result from transcriptional and/or translational changes, whereas rOCT1 deficits may be due to posttranscriptional alterations.
Insights
Experimental diabetes impairs organic cation transport in rats by reducing key transporter proteins. Insulin treatment reversed these deficits, suggesting potential therapeutic targets for diabetic kidney disease.
Area of Science:
- Nephrology
- Molecular Biology
- Diabetology
Background:
- Organic cation transport is crucial for kidney function.
- A functional deficit in organic cation transport has been observed in diabetic rats.
- The underlying mechanism for this deficit remains unclear.
Purpose of the Study:
- To investigate the hypothesis that experimental diabetes decreases the expression of organic cation transporters at the basolateral membrane.
- To elucidate the molecular mechanisms behind impaired organic cation transport in diabetes.
Main Methods:
- Streptozotocin-induced diabetic rat model with varying durations.
- Kinetic analysis of tetraethylammonium accumulation in proximal tubular cells.
- Northern and immunoblot analysis for organic cation transporter (OCT) expression (rOCT1, rOCT2).
- Insulin treatment as an intervention.
Main Results:
- Diabetic rats showed significantly lower Vmax for tetraethylammonium accumulation, indicating reduced transporter function.
- Protein expression of rOCT1 and rOCT2 decreased with diabetes duration (up to 50% and 70%, respectively).
- roct2 mRNA levels decreased by 50%, while roct1 mRNA remained unchanged; insulin prevented these reductions.
Conclusions:
- Experimental diabetes reduces the expression of organic cation transporters rOCT1 and rOCT2.
- Diabetes affects roct2 expression transcriptionally and/or translationally, but rOCT1 deficits may stem from posttranscriptional alterations.
- Insulin therapy can restore normal transporter levels, highlighting its potential in managing diabetic nephropathy.
Related Concept Videos
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Cell Specific Gene Expression